Fremman Capital Acquires Majority Stake in Diesse Diagnostica Senese
Deal News | Jan 29, 2025 | Legal Community Italy
Fremman Capital, a private equity firm focused on Europe's mid-market, has acquired a majority stake in Diesse Diagnostica Senese, an Italian company specializing in in vitro diagnostic systems and reagents. The acquisition was facilitated by A&O Shearman, which provided legal assistance to Fremman Capital. Diesse was previously owned by private equity firm Archimed, which was advised by Dentons, while the management team, retaining a minority stake post-acquisition, received legal advice from Lawal. This deal is contingent on certain conditions being met. Fremman aims to continue leveraging the existing management team to drive Diesse's growth. The transaction highlights strategic legal involvement from multiple firms, each covering diverse aspects of the deal, including corporate, antitrust, compliance, and employment law.
Sectors
- Private Equity
- Healthcare
- Legal Services
Geography
- Italy – Diesse Diagnostica Senese is an Italian company, and the legal proceedings predominantly involved Italian branches of the law firms.
- Europe – Fremman Capital targets the European mid-market, demonstrating their geographical investment focus.
Industry
- Private Equity – Fremman Capital is a private equity firm focused on mid-market investments in Europe, and their involvement highlights activity in the Private Equity sector.
- Healthcare – Diesse Diagnostica Senese operates in the healthcare sector, specifically in the development of in vitro diagnostic systems and reagents.
- Legal Services – Multiple law firms were involved in the transaction, supporting different parties and aspects, including corporate, antitrust, compliance, and employment law.
Financials
- Not disclosed – The financial terms of the acquisition were not publicly disclosed in the article.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Fremman Capital | Buyer | Company | Private equity firm with a focus on the European mid-market. |
| Diesse Diagnostica Senese | Target company | Company | Italian company producing in vitro diagnostic systems and reagents. |
| Archimed | Vendor | Company | Private equity firm selling its majority stake in Diesse Diagnostica Senese. |
| A&O Shearman | Legal advisor for Fremman Capital | Company | Law firm advising Fremman Capital on the acquisition. |
| Dentons | Legal advisor for Archimed | Company | Law firm advising Archimed on legal aspects of the transaction. |
| Lawal Legal & Tax Advisory | Legal advisor for Diesse's management | Company | Law firm advising Diesse's management team maintaining a minority stake. |